KENILWORTH, N.J., Aug. 11 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced the launch of CLARITIN Eye, an antihistamine eye drop strong enough to control itchy eyes all day or all night. Found in the eye care aisle wherever over-the-counter products are sold, CLARITIN Eye works in minutes to relieve the itch of allergy eyes for up to 12 hours with just one drop.
To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/claritin/39444/
"Itchy eyes are an extremely bothersome symptom for allergy sufferers and can be caused by indoor or outdoor allergens such as dust, pet dander, mold or pollen. CLARITIN Eye relieves the itch at the source by blocking the histamine that causes itchy eyes," said Dr. John O'Mullane, group vice president, research and development, Schering-Plough Consumer Health Care. "We're excited to add this new allergy eye product to the line of non-drowsy CLARITIN allergy products."
To support the introduction of the new product, the makers of CLARITIN will kick off the launch with national advertising as well as launching the brand's first official Facebook page. The page features a "CLARITIN Eye Makeover" application where fans are invited to upload their favorite photos and use the application to clear the red eye in their pictures. The page, available at facebook.com/claritineye, offers resources for allergy sufferers including facts, tips and a photo gallery where visitors can show how they "Live Claritin Clear(R)."
Like all non-drowsy CLARITIN products, new CLARITIN Eye is available without a prescription and can be found in most food, drug or mass retailers. CLARITIN Eye drops are located in the eye care aisle and is safe and effective for adults and children as young as three when used as directed. For more information on allergies and non-drowsy treatment options, visit CLARITIN.com.
All CLARITIN brand products are non-drowsy and available without a prescription. CLARITIN provides powerful, 24-hour allergy relief and comes in a variety of forms, including: CLARITIN(R) Tablets, CLARITIN(R) Liqui-Gels(R), an easy-to-swallow liquid-filled capsule, and CLARITIN(R) RediTabs(R), a quickly dissolving tablet for ages 6 and older. In addition, CLARITIN(R) 12-Hour RediTabs(R) provide the flexibility to manage allergy symptoms all day or all night. CLARITIN-D(R) is available behind-the-counter in 12 or 24-hour extended release tablets and also includes the decongestant pseudoephedrine for powerful nasal congestion relief. CHILDREN'S CLARITIN (R) comes in great-tasting Grape Chewables or Syrup forms and is safe and effective for kids 2 and older when used as directed.
Finally, CLARITIN Eye is an antihistamine eye drop found in the eye care aisle that works in minutes and relieves the itch of allergy eyes for up to 12 hours.
CLARITIN is the No. 1 physician-recommended and pediatrician-recommended non-drowsy over-the-counter allergy brand. The CLARITIN Rx-to-OTC switch in 2002 was the largest switch ever - and the first and only for a non-drowsy antihistamine. For more information on allergies and treatment, visit www.CLARITIN.com.
Schering-Plough Consumer Health Care is the U.S. over-the-counter (OTC) and consumer products business unit of Schering-Plough an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.
Copyright©2009 PR Newswire.
All rights reserved